MGNet: Investigating the Characteristics of Natural Killer Cells in Patients with Autoantibody-Mediated Autoimmune Diseases
Apr 24, 2024 ·
1m 42s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in The Journal of Immunology on March 1, 2024, titled "A Noncanonical...
show more
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in The Journal of Immunology on March 1, 2024, titled "A Noncanonical CD56dimCD16dim/− NK Cell Subset Indicative of Prior Cytotoxic Activity Is Elevated in Patients with Autoantibody-Mediated Neurologic Diseases."
Read the paper here: https://journals.aai.org/jimmunol/article-abstract/212/5/785/266624/A-Noncanonical-CD56dimCD16dim-NK-Cell-Subset?redirectedFrom=fulltext
Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
show less
Read the paper here: https://journals.aai.org/jimmunol/article-abstract/212/5/785/266624/A-Noncanonical-CD56dimCD16dim-NK-Cell-Subset?redirectedFrom=fulltext
Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
Information
| Author | RDCRN |
| Organization | RDCRN |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comments